Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;146(3):318.
doi: 10.1001/archdermatol.2009.379.

Trends in dermatology: melanoma incidence

Affiliations

Trends in dermatology: melanoma incidence

Darrell S Rigel. Arch Dermatol. 2010 Mar.
No abstract available

PubMed Disclaimer

Similar articles

Cited by

  • Meta-analysis of number needed to treat for diagnosis of melanoma by clinical setting.
    Petty AJ, Ackerson B, Garza R, Peterson M, Liu B, Green C, Pavlis M. Petty AJ, et al. J Am Acad Dermatol. 2020 May;82(5):1158-1165. doi: 10.1016/j.jaad.2019.12.063. Epub 2020 Jan 11. J Am Acad Dermatol. 2020. PMID: 31931085 Free PMC article.
  • Clinical protein science in translational medicine targeting malignant melanoma.
    Gil J, Betancourt LH, Pla I, Sanchez A, Appelqvist R, Miliotis T, Kuras M, Oskolas H, Kim Y, Horvath Z, Eriksson J, Berge E, Burestedt E, Jönsson G, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Horvatovich P, Murillo JR, Sugihara Y, Welinder C, Wieslander E, Lee B, Lindberg H, Pawłowski K, Kwon HJ, Doma V, Timar J, Karpati S, Szasz AM, Németh IB, Nishimura T, Corthals G, Rezeli M, Knudsen B, Malm J, Marko-Varga G. Gil J, et al. Cell Biol Toxicol. 2019 Aug;35(4):293-332. doi: 10.1007/s10565-019-09468-6. Epub 2019 Mar 21. Cell Biol Toxicol. 2019. PMID: 30900145 Free PMC article.
  • Therapeutic options in cutaneous melanoma: latest developments.
    Amaria RN, Lewis KD, Gonzalez R. Amaria RN, et al. Ther Adv Med Oncol. 2011 Sep;3(5):245-51. doi: 10.1177/1758834011415308. Ther Adv Med Oncol. 2011. PMID: 21957431 Free PMC article.
  • Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.
    Park JY, Amankwah EK, Anic GM, Lin HY, Walls B, Park H, Krebs K, Madden M, Maddox K, Marzban S, Fang S, Chen W, Lee JE, Wei Q, Amos CI, Messina JL, Sondak VK, Sellers TA, Egan KM. Park JY, et al. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):827-34. doi: 10.1158/1055-9965.EPI-12-1129. Epub 2013 Mar 5. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23462921 Free PMC article.
  • Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.
    Friedman KM, Prieto PA, Devillier LE, Gross CA, Yang JC, Wunderlich JR, Rosenberg SA, Dudley ME. Friedman KM, et al. J Immunother. 2012 Jun;35(5):400-8. doi: 10.1097/CJI.0b013e31825898c5. J Immunother. 2012. PMID: 22576345 Free PMC article.